• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To register, simply click the Register button at the top right.

Intravenous Vitamin C Administration Reduces Fatigue in Office Workers: 2xBlind RCT


Senior Member
Free full text: http://www.nutritionj.com/content/pdf/1475-2891-11-7.pdf (provisional)

Intravenous Vitamin C Administration Reduces Fatigue in Office Workers: A Double-blind Randomized Controlled Trial

Sang-Yeon Suh, Woo Kyung Bae, Hong-Yup Ahn, Sung-Eun Choi, Gyou-Chul Jung and Chang Hwan Yeom

Nutrition Journal 2012, 11:7 doi:10.1186/1475-2891-11-7

Published: 20 January 2012



Studies of the efficacy of vitamin C treatment for fatigue have yielded inconsistent results.

One of the reasons for this inconsistency could be the difference in delivery routes.

Therefore, we planned a clinical trial with intravenous vitamin C administration.


We evaluated the effect of intravenous vitamin C on fatigue in office workers.

A group of 141 healthy volunteers, aged 20 to 49 years participated in this randomized, double-blind, controlled clinical trial.

The trial group received 10 grams of vitamin C with normal saline intravenously, while the placebo group received normal saline only.

Since vitamin C is a well-known antioxidant, oxidative stress was measured.

Fatigue score, oxidative stress, and plasma vitamin C levels were measured before intervention, and again two hours and one day after intervention.

Adverse events were monitored.


The fatigue scores measured at two hours after intervention and one day after intervention were significantly different between the two groups (p = 0.004); fatigue scores decreased in the vitamin C group after two hours and remained lower for one day.

Trial also led to higher plasma vitamin C levels and lower oxidative stress compared to the placebo group (p < 0.001, p < 0.001, respectively).

When data analysis was refined by dividing each group into high-baseline and low-baseline subgroups, it was observed that fatigue was reduced in the lower baseline vitamin C level group after two hours and after one day (p = 0.004).

The same did not hold for the higher baseline group (p = 0.206).


Thus, intravenous vitamin C reduced fatigue at two hours, and the effect persisted for one day.

There were no significant differences in adverse events between two groups.

High dose intravenous vitamin C proved to be safe and effective against fatigue in this study.

The clinical trial registration of this trial is ClinicalTrials.gov NCT00633581.

* I gave each sentence its own paragraph.
Paper has a few Chronic Fatigue Syndrome references.